Nielsen: #1 Holder of Pervasive Neurotech Intellectual Property*

Nielsen is a glob­al orga­ni­za­tion focus­ing on infor­ma­tion mea­sure­ment. With a reach of over 100 coun­tries, Nielsen ana­lyzes trends in con­sumer behav­ior, includ­ing which prod­ucts con­sumers buy and which video con­tent con­sumers watch. In 2011 Nielsen acquired Neu­ro­Fo­cus to aug­ment its Prod­uct Inno­va­tion Prac­tice. Neu­ro­fo­cus is an agency that uses EEG tech­nol­o­gy to under­stand how con­sumers react to adver­tis­ing and packaging.

• Loca­tion: New York, NY
• Stock Tick­er: NYSE:NLSN
• Num­ber of employ­ees: 10,000+

*The Nielsen Com­pa­ny ranked #1 in Sharp­Brains’ Per­va­sive Neu­rotech IP Strength Index, thanks to patents such as:

• US8392250: Neu­ro-response eval­u­at­ed stim­u­lus in vir­tu­al real­i­ty environments
• US8392251: Loca­tion aware pre­sen­ta­tion of stim­u­lus material
• US8655428: Neu­ro-response data synchronization
• US6099319: Neu­roimag­ing as a mar­ket­ing tool

In the news –NIELSEN LEADS THE FIELD IN SHARPBRAINS’ REPORT ON INTELLECTUAL PROPERTY OF PERVASIVE NEUROTECHNOLOGY (The Wall Street Transcript):

“Nielsen has made a sub­stan­tial invest­ment in neu­rotech­nol­o­gy over the past sev­er­al years, which is reflect­ed in the size of our patent port­fo­lio,” said Joe Wilke, Pres­i­dent, Nielsen Neu­ro. “It’s grat­i­fy­ing to be rec­og­nized by the Sharp­Brains study as the leader in this excit­ing new area.”

The abil­i­ty to mon­i­tor and inter­face with the brain has wide rang­ing pos­si­bil­i­ties.  “Once we start­ed the gran­u­lar analy­sis of the intel­lec­tu­al prop­er­ty data, we were amazed by the wide vari­ety of appli­ca­tions we found. This clear­ly demon­strates neu­rotech­nol­o­gy has gone beyond the med­ical domain, with non-med­ical cor­po­ra­tions devel­op­ing neu­rotech­nolo­giesto enhance work and life,” said Alvaro Fer­nan­dez, CEO Sharp­Brains. “We were impressed by the breadth and depth of Nielsen’s IP port­fo­lio, show­ing a trans­for­ma­tion under­way in how con­sumer research and mar­ket­ing are done.”

To learn more about Sharp­Brains’ take on the orga­ni­za­tion’s #Per­va­siveNeu­rotech IP port­fo­lio, and over­all data and trends, click on Per­va­sive Neu­rotech­nol­o­gy: A Ground­break­ing Analy­sis of 10,000+ Patent Fil­ings Trans­form­ing Med­i­cine, Health, Enter­tain­ment, and Busi­ness.